Bookmark and Share

Compound Summary for: CID 9803963

GW 501516

Also known as: 317318-70-0; GW501516; GW-501516; Endurobol; GSK-516; UNII-7I2HA1NU22; GW 1516; GW1516; CHEBI:73726
Molecular Formula: C21H18F3NO3S2   Molecular Weight: 453.49773   InChIKey: YDBLKRPLXZNVNB-UHFFFAOYSA-N
GW-501516 is a peroxisome proliferator-activator receptor-delta agonist for the potential treatment of dyslipidemia. It is developed by GlaxoSmithKline. This drug is in Phase II clinical trials .   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Biomedical Effects and Toxicity
Biological Test Results
Chemical and Physical Properties
_ _